|
|
Previous Article | Table of Contents | Next Article 
The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute
megakaryoblastic leukemia: a Pediatric Oncology Group Study
A Carroll, C Civin, N Schneider, G Dahl, A Pappo, P Bowman, A Emami, S Gross, C Alvarado and C Phillips
Laboratory of Medical Genetics, University of Alabama, Birmingham.
We report the nonrandom occurrence and frequency of the t(1;22)(p13;q13) in
acute myeloid leukemia (AML) and its close association with the
French-American-British M7 subtype of AML in infants (less than 1 year).
This chromosomal abnormality occurred in 6 of 252 (2.4%) children and
adolescents with AML (6 of 28 infants, 22%; 6 of 18 M7 AML cases overall,
33%; and 6 of 6 M7 cases in infants). Infants with AML of M7 subtype and
the t(1;22) often presented with prominent abdominal masses. Two of these
infants were not treated and died early. Three of four treated infants
entered complete remission with therapy for AML; the remaining infant died
of hemorrhage on day 8. Of the three infants who entered remission, only
one remains alive and disease free at 5+ months. The other two infants
relapsed in the bone marrow at 5 and 2 months from the start of therapy,
respectively. We conclude that M7 AML with the t(1;22) usually presents in
infants with extensive infiltration of abdominal organs by leukemic cells
and may confer a poor prognosis despite intensive AML-directed treatment.
Identification of this nonrandom translocation exclusively in infants with
acute megakaryoblastic leukemia (AMkL) implies that it may serve as an
additional diagnostic marker for this disease and links it to the
pathogenesis of AMkL in infants.
Volume 78,
Issue 3,
pp. 748-752,
08/01/1991
Copyright © 1991 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Descot, M. Rex-Haffner, G. Courtois, D. Bluteau, A. Menssen, T. Mercher, O. A. Bernard, R. Treisman, and G. Posern
OTT-MAL Is a Deregulated Activator of Serum Response Factor-Dependent Gene Expression
Mol. Cell. Biol.,
October 15, 2008;
28(20):
6171 - 6181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Forestier, S. Izraeli, B. Beverloo, O. Haas, A. Pession, K. Michalova, B. Stark, C. J. Harrison, A. Teigler-Schlegel, and B. Johansson
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
Blood,
February 1, 2008;
111(3):
1575 - 1583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ma, M. J. Renda, L. Wang, E.-c. Cheng, C. Niu, S. W. Morris, A. S. Chi, and D. S. Krause
Rbm15 Modulates Notch-Induced Transcriptional Activation and Affects Myeloid Differentiation
Mol. Cell. Biol.,
April 15, 2007;
27(8):
3056 - 3064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Raffel, T. Mercher, H. Shigematsu, I. R. Williams, D. E. Cullen, K. Akashi, O. A. Bernard, and D. G. Gilliland
Ott1(Rbm15) has pleiotropic roles in hematopoietic development
PNAS,
April 3, 2007;
104(14):
6001 - 6006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ge, T. L. Jensen, L. H. Matherly, and J. W. Taub
Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines
Blood,
February 15, 2003;
101(4):
1551 - 1557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dastugue, M. Lafage-Pochitaloff, M.-P. Pages, I. Radford, C. Bastard, P. Talmant, M. J. Mozziconacci, C. Leonard, C. Bilhou-Nabera, C. Cabrol, et al.
Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH)
Blood,
June 28, 2002;
100(2):
618 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. H. Athale, B. I. Razzouk, S. C. Raimondi, X. Tong, F. G. Behm, D. R. Head, D. K. Srivastava, J. E. Rubnitz, L. Bowman, C.-H. Pui, et al.
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience
Blood,
June 15, 2001;
97(12):
3727 - 3732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mercher, M. B.-L. Coniat, R. Monni, M. Mauchauffe, F. N. Khac, L. Gressin, F. Mugneret, T. Leblanc, N. Dastugue, R. Berger, et al.
Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia
PNAS,
May 8, 2001;
98(10):
5776 - 5779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Tallman, D. Neuberg, J. M. Bennett, C. J. Francois, E. Paietta, P. H. Wiernik, G. Dewald, P. A. Cassileth, M. M. Oken, and J. M. Rowe
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience
Blood,
October 1, 2000;
96(7):
2405 - 2411.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|